US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,344.16

-6.3169-0.47%

Number of Gainers:15

Number of Losers:5

Number of Flat:- -

PE:- -

High:1,358.14

Open:1,352.65

Low:1,337.79

Close:1,350.48

Loading ...

SAP SE (0NW4): New Buy Recommendation for This Technology Giant

BUZZ-Street View: Abbott's effective management could help it triumph over tariffs

Moderna’s Market Challenges: Hold Rating Amid Regulatory Uncertainty and Competitive Pressures

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Blueprint Medicines (BPMC)

Abbott : Jefferies Raises Target Price to $137 From $135

THOMSON REUTERS

Abbott : Btig Raises Target Price to $145 From $140

THOMSON REUTERS

Abbott : Piper Sandler Raises Target Price to $145 From $133

THOMSON REUTERS

Gilead Sciences (GILD) Stock Moves -0.74%: What You Should Know

BRIEF-ACIP Votes To Expand Recommendation For Pfizer’S RSV Vaccine Abrysvo To Include Adults Aged 50 To 59 At Increased Risk Of Disease

ACIP votes to expand recommendation for Pfizer’s RSV vaccine

Acip Votes to Expand Recommendation for Pfizer’s Rsv Vaccine Abrysvo® to Include Adults Aged 50 to 59 at Increased Risk of Disease

THOMSON REUTERS

ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease

Novavax (NasdaqGS:NVAX) Study Shows Reduced Symptoms With New COVID-19 Vaccine Formula

Simply Wall St.

BUZZ-Abbott on track for best day in 2 years after reaffirming forecast amid tariff risks

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®

Is Johnson & Johnson (JNJ) the Best Dividend Monarch to Invest in Now?

Abbott Labs Forecasts Tariff Impact of a 'Few Hundred Million Dollars' -- WSJ

Abbott Maintains Profit Forecast, Invests $500 Million in US Amid Tariffs

Abbott Labs sees demand for diabetes products jump, and the stock surges

Is Gilead Sciences Inc. (NASDAQ:GILD) the Most Undervalued Quality Stock to Buy Now?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1344.1606,"timestamp":1745438399999,"preClose":1350.4775,"halted":0,"volume":116544837,"delay":0,"changeRate":-0.004678,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-6.316895,"latestTime":"04-23 16:00:00 EDT","open":1352.6482,"high":1358.1393,"low":1337.7921,"amount":5630583813.539834,"amplitude":0.015067,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745501400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.712018,"peRate":24.625548,"turnoverRate":0.007511,"increases":15,"decrements":5,"flats":0,"marketCap":1111877193875.5,"floatMarketCap":1090499613844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1358.1393,"amplitude":0.015067,"preClose":1350.4775,"low":1337.7921,"pbRate":"3.712018","latestPrice":1344.1606,"volume":116544837,"delay":0,"open":1352.6482,"prevYearClose":1274.8187,"prevWeekClose":1341.7848,"prevMonthClose":1427.887,"prevQuarterClose":1427.887,"fiveDayClose":1326.1057,"twentyDayClose":1396.009,"sixtyDayClose":1358.9425,"secType":"PLATE","market":"US","turnoverRate":0.007511,"peRate":24.625548,"marketCap":1111877193875.5,"floatMarketCap":1090499613844,"timestamp":1745438399999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":15,"down":5,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528879125","title":"SAP SE (0NW4): New Buy Recommendation for This Technology Giant","url":"https://stock-news.laohu8.com/highlight/detail?id=2528879125","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528879125?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:18","pubTimestamp":1744885119,"startTime":"0","endTime":"0","summary":"In a report released today, Andreas Wolf from Warburg Research maintained a Buy rating on SAP SE (0NW4 – Research Report), with a price target of €...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sap-se-0nw4-new-buy-recommendation-for-this-technology-giant-29?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sap-se-0nw4-new-buy-recommendation-for-this-technology-giant-29?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BNTX","BK4139","BK4585","BK4568","BK4551","BK4535","BK4548"],"gpt_icon":0},{"id":"2528760455","title":"BUZZ-Street View: Abbott's effective management could help it triumph over tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2528760455","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528760455?lang=en_us&edition=fundamental","pubTime":"2025-04-17 17:16","pubTimestamp":1744881378,"startTime":"0","endTime":"0","summary":"BUZZ-Street View: Abbott's effective management could help it triumph over tariffs** Medical device maker Abbott Laboratories ABT.N maintained its annual profit forecast on Wednesday and said it expected U.S. tariffs to hit earnings by a \"few hundred million dollars\"** Median PT of 28 brokerages covering the stock is $145 - LSEG dataOPTIMISM FOR MEDTECH** J.P.Morgan  says it is optimistic about co, citing strong fundamentals and effective management to mitigate tariff impacts** Piper Sandler  says it is confident in co's diversified business model and its ability to navigate through periods of uncertainty while delivering sustainable growth** TD Cowen  sees co mitigating tariff impacts through strategic manufacturing adjustments and leveraging past successes** \"We saw ABT rapidly respond to the COVID pandemic and build a multi billion-dollar Covid testing franchise in very little time. This precedent should give investors confidence that the plant optimization initiatives can succeed i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nL4N3QV0FA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1914381329.SGD","LU2237957811.SGD","IE00B4R5TH58.HKD","BK4581","IE00BJT1NW94.SGD","BK4592","IE00B2B36J28.USD","LU2468319806.SGD","SG9999002224.SGD","SG9999002232.USD","LU1023059063.AUD","LU2089984988.USD","BK4568","SGXZ23171101.USD","BK4082","IE0002141913.USD","LU2237957902.USD","LU0266013472.USD","LU0122379950.USD","ABT","LU1057294990.SGD","LU0868494617.USD","SG9999004303.SGD","LU2112291526.USD","BK4566","BK4585","IE0009355771.USD","LU0234572021.USD","BK4533","LU1691799644.USD","LU1721429402.USD","LU1989763427.SGD","LU2133065610.SGD","BK4504","LU1721429741.USD","BK4588","LU1061106388.HKD","LU0170899867.USD","LU1989763690.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2528505762","title":"Moderna’s Market Challenges: Hold Rating Amid Regulatory Uncertainty and Competitive Pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2528505762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528505762?lang=en_us&edition=fundamental","pubTime":"2025-04-17 16:45","pubTimestamp":1744879548,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their neutral stance on MRNA stock, giving a Hold rating on April 14. Myles Minter has given his ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/modernas-market-challenges-hold-rating-amid-regulatory-uncertainty-and-competitive-pressures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/modernas-market-challenges-hold-rating-amid-regulatory-uncertainty-and-competitive-pressures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4532","MRNA","BK4588","BK4501","BK4585","BK4568","BK4551","BK4548","BK4533","BK4534"],"gpt_icon":0},{"id":"2528765220","title":"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Blueprint Medicines (BPMC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528765220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528765220?lang=en_us&edition=fundamental","pubTime":"2025-04-17 16:11","pubTimestamp":1744877473,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abbott Laboratories (ABT – Research Report) and Bl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-and-blueprint-medicines-bpmc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-and-blueprint-medicines-bpmc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0122379950.USD","LU2237957811.SGD","BK4505","SGXZ23171101.USD","LU1989763690.USD","BK4585","LU0234572021.USD","LU1721429741.USD","BK4082","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4592","SG9999004303.SGD","IE00B2B36J28.USD","SG9999002232.USD","LU0170899867.USD","ABT","BK4566","LU1023059063.AUD","LU1914381329.SGD","BK4588","LU0266013472.USD","LU2468319806.SGD","LU0868494617.USD","LU2133065610.SGD","LU2089984988.USD","BPMC","BK4581","IE0002141913.USD","LU2237957902.USD","BK4533","BK4504","BK4568","HCSG","IE00BFTCPJ56.SGD","LU2112291526.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","SG9999002224.SGD","LU1989763427.SGD","IE0009355771.USD","LU0053671581.USD","LU1691799644.USD","BK4139","BK4137","IE00BJT1NW94.SGD","LU1721429402.USD"],"gpt_icon":0},{"id":"2528751366","title":"Abbott : Jefferies Raises Target Price to $137 From $135","url":"https://stock-news.laohu8.com/highlight/detail?id=2528751366","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528751366?lang=en_us&edition=fundamental","pubTime":"2025-04-17 14:40","pubTimestamp":1744872035,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV0ZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4504","LU1914381329.SGD","LU2237957811.SGD","SGXZ23171101.USD","IE00BFTCPJ56.SGD","BK4082","BK4585","LU1057294990.SGD","IE0002141913.USD","LU2089984988.USD","LU2468319806.SGD","BK4581","IE00B2B36J28.USD","LU1691799644.USD","LU1989763690.USD","LU1989763427.SGD","BK4533","BK4588","IE00B4R5TH58.HKD","LU2112291526.USD","LU1061106388.HKD","LU0868494617.USD","LU1721429402.USD","LU1721429741.USD","IE0009355771.USD","BK4566","LU0234572021.USD","SG9999002224.SGD","IE00BJT1NW94.SGD","LU2133065610.SGD","LU0170899867.USD","ABT","BK4568","LU1023059063.AUD","LU0122379950.USD","LU2237957902.USD","BK4592","SG9999002232.USD","LU0266013472.USD","IE00BJJMRZ35.SGD","SG9999004303.SGD"],"gpt_icon":0},{"id":"2528758730","title":"Abbott : Btig Raises Target Price to $145 From $140","url":"https://stock-news.laohu8.com/highlight/detail?id=2528758730","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528758730?lang=en_us&edition=fundamental","pubTime":"2025-04-17 13:24","pubTimestamp":1744867470,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV0XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","ABT","SG9999002232.USD","LU1914381329.SGD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU2237957811.SGD","BK4585","LU1057294990.SGD","SG9999002224.SGD","IE0002141913.USD","BK4581","LU0868494617.USD","LU1061106388.HKD","LU2112291526.USD","BK4568","LU2237957902.USD","BK4533","LU2468319806.SGD","LU1691799644.USD","IE0009355771.USD","LU1989763690.USD","LU0122379950.USD","BK4504","LU1721429402.USD","SG9999004303.SGD","BK4592","IE00B2B36J28.USD","BK4566","IE00BJT1NW94.SGD","LU1721429741.USD","LU2089984988.USD","LU2133065610.SGD","IE00B4R5TH58.HKD","LU0170899867.USD","LU0266013472.USD","LU1989763427.SGD","SGXZ23171101.USD","LU0234572021.USD","BK4588","BK4082"],"gpt_icon":0},{"id":"2528732860","title":"Abbott : Piper Sandler Raises Target Price to $145 From $133","url":"https://stock-news.laohu8.com/highlight/detail?id=2528732860","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528732860?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:08","pubTimestamp":1744862907,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV044:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU1721429741.USD","LU1023059063.AUD","LU1061106388.HKD","LU0170899867.USD","BK4082","LU2133065610.SGD","SGXZ23171101.USD","ABT","LU1721429402.USD","SG9999002224.SGD","BK4581","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4533","BK4504","LU1914381329.SGD","LU1691799644.USD","LU0234572021.USD","LU1989763427.SGD","LU0266013472.USD","BK4566","SG9999004303.SGD","IE00BJT1NW94.SGD","BK4592","BK4568","LU2237957811.SGD","LU2468319806.SGD","LU2237957902.USD","IE00B4R5TH58.HKD","IE0002141913.USD","LU1057294990.SGD","LU1989763690.USD","IE00BFTCPJ56.SGD","LU2112291526.USD","IE0009355771.USD","SG9999002232.USD","LU2089984988.USD","IE00B2B36J28.USD","LU0868494617.USD","BK4588"],"gpt_icon":0},{"id":"2528578599","title":"Gilead Sciences (GILD) Stock Moves -0.74%: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2528578599","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528578599?lang=en_us&edition=fundamental","pubTime":"2025-04-17 06:00","pubTimestamp":1744840815,"startTime":"0","endTime":"0","summary":"The most recent trading session ended with Gilead Sciences  standing at $104.90, reflecting a -0.74% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss of 2.24%. Meanwhile, the Dow experienced a drop of 1.73%, and the technology-dominated Nasdaq saw a decrease of 3.07%.Shares of the HIV and hepatitis C drugmaker have depreciated by 4.13% over the course of the past month, outperforming the Medical sector's loss of 7.47% and the S&P 500's loss of 4.17%.Market participants will be closely following the financial results of Gilead Sciences in its upcoming release. The company plans to announce its earnings on April 24, 2025. In that report, analysts expect Gilead Sciences to post earnings of $1.73 per share. This would mark year-over-year growth of 231.06%. At the same time, our most recent consensus estimate is projecting a revenue of $6.83 billion, reflecting a 2.18% rise from the equivalent quarter last year.The Zacks Industry Rank ga","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-gild-stock-moves-220015275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4566","LU0234570918.USD","BK4583","BK4139","IE0002270589.USD","LU0109394709.USD","LU1066053197.SGD","LU1430594728.SGD","BK4532","LU1066051498.USD","LU0058720904.USD","BK4585","LU0889565916.HKD","BK4550","LU1839511570.USD","IE00BZ1G4Q59.USD","LU2468319806.SGD","IE00B3T34201.USD","LU1585245621.USD","IE00B19Z3581.USD","LU1571399168.USD","GILD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4588","LU0320765992.SGD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU2089984988.USD","BK4568","LU2087621335.USD","IE00B7SZLL34.SGD","BK4578"],"gpt_icon":0},{"id":"2528704562","title":"BRIEF-ACIP Votes To Expand Recommendation For Pfizer’S RSV Vaccine Abrysvo To Include Adults Aged 50 To 59 At Increased Risk Of Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2528704562","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528704562?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:32","pubTimestamp":1744835523,"startTime":"0","endTime":"0","summary":"BRIEF-ACIP Votes To Expand Recommendation For Pfizer’S RSV Vaccine Abrysvo To Include Adults Aged 50 To 59 At Increased Risk Of DiseaseApril 16 (Reuters) - Pfizer Inc PFE.N:ACIP VOTES TO EXPAND RECOMM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nTUA5KWNWL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","IE00B19Z3B42.SGD","BK4550","BK4581","LU0225771236.USD","LU0225284248.USD","BK4568","LU0058720904.USD","LU0170899867.USD","SGXZ57979304.SGD","BK4599","LU1057294990.SGD","IE00B19Z3581.USD","LU0321505439.SGD","LU1066053197.SGD","LU0306807586.USD","IE000M9KFDE8.USD","LU1883839398.USD","LU1894683264.USD","LU0456855351.SGD","SG9999002232.USD","BK4585","LU1894683348.USD","SG9999003800.SGD","SG9999001176.SGD","LU0985481810.HKD","LU0289739699.SGD","BK4534","BK4592","PFE","SG9999002224.SGD","LU0868494617.USD","BK4533","SG9999001176.USD","LU0306806265.USD","IE0002270589.USD","IE00BLSP4452.SGD","BK4007","BK4588","SG9999011175.SGD","LU0234572021.USD","IE00BBT3K403.USD","LU0122379950.USD","LU1023059063.AUD","IE00BLSP4239.USD","LU1066051498.USD","SG9999013999.USD"],"gpt_icon":0},{"id":"2528089912","title":"ACIP votes to expand recommendation for Pfizer’s RSV vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2528089912","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528089912?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:20","pubTimestamp":1744834835,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) announced that the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acip-votes-to-expand-recommendation-for-pfizers-rsv-vaccine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acip-votes-to-expand-recommendation-for-pfizers-rsv-vaccine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0306806265.USD","IE0002270589.USD","IE000M9KFDE8.USD","BK4533","LU0456855351.SGD","LU1066051498.USD","BK4581","LU1023059063.AUD","IE00BLSP4452.SGD","LU0321505868.SGD","BK4007","IE00BBT3K403.USD","LU1057294990.SGD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4550","IE00B19Z3581.USD","LU0225771236.USD","BK4585","SG9999013999.USD","LU0868494617.USD","BK4588","LU1894683348.USD","LU1894683264.USD","PFE","SG9999002224.SGD","BK4534","BK4568","IE00BLSP4239.USD","LU0225284248.USD","LU1883839398.USD","BK4599","LU0985481810.HKD","SG9999003800.SGD","LU0170899867.USD","SG9999011175.SGD","LU0234572021.USD","BK4592","LU0058720904.USD","LU0289739699.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU0122379950.USD","SG9999001176.USD","LU0306807586.USD","SG9999001176.SGD"],"gpt_icon":0},{"id":"2528227722","title":"Acip Votes to Expand Recommendation for Pfizer’s Rsv Vaccine Abrysvo® to Include Adults Aged 50 to 59 at Increased Risk of Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2528227722","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528227722?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:15","pubTimestamp":1744834501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nTUA5KWNWL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BBT3K403.USD","LU0306807586.USD","BK4550","IE0002270589.USD","SG9999001176.USD","LU1894683264.USD","BK4599","LU1057294990.SGD","BK4568","SG9999013999.USD","BK4534","LU0170899867.USD","LU0122379950.USD","LU0225284248.USD","LU0306806265.USD","SG9999011175.SGD","PFE","BK4585","IE00B19Z3B42.SGD","LU0985481810.HKD","LU0058720904.USD","LU0321505439.SGD","IE00B19Z3581.USD","BK4007","LU0321505868.SGD","LU1066053197.SGD","SG9999003800.SGD","BK4592","LU1883839398.USD","LU0289739699.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0234572021.USD","BK4533","IE00BLSP4239.USD","LU0456855351.SGD","BK4588","LU1023059063.AUD","LU0868494617.USD","SG9999001176.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU1066051498.USD","LU0225771236.USD","LU1894683348.USD","IE000M9KFDE8.USD","BK4581"],"gpt_icon":0},{"id":"2528920680","title":"ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2528920680","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528920680?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:15","pubTimestamp":1744834500,"startTime":"0","endTime":"0","summary":"Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74. NEW YORK, April 16, 2025----Pfizer Inc.  announced today that the U.S. Centers for Disease Control and Prevention’s  Advisory Committee on Immunization Practices  voted to expand its recommendation for the use of respiratory syncytial virus  vaccines approved for adults 50-59 years of age at increased risk of RSV-associated lower respiratory tract disease . This includes ABRYSVO , which in October 2024, the U.S. Food and Drug Administration approved for the prevention of RSV-associated LRTD in adults aged 18 to 59 at increased risk of severe disease.ABOUT ABRYSVOPfizer currently is the only company with an RSV vaccine to help protect adults aged 60 and older, and adults 18 and older at increased risk of lower respiratory tract disease caused by RSV , as well as infants through maternal immunization. ABRYSVO is an unadjuvanted, bivalent vaccine that was designed","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acip-votes-expand-recommendation-pfizer-201500828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0321505439.SGD","BK4534","BK4516","BK4574","BK4555","IE0002270589.USD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0225771236.USD","LU1057294990.SGD","LU0868494617.USD","LU0058720904.USD","LU0225284248.USD","BK4585","CDC","LU1066051498.USD","SG9999003800.SGD","BK4550","IE000M9KFDE8.USD","LU1883839398.USD","SG9999013999.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","SG9999002232.USD","LU0985481810.HKD","LU0306807586.USD","IE00BLSP4239.USD","LU0306806265.USD","F","LU0122379950.USD","BK4007","LU0289739699.SGD","BK4588","LU0456855351.SGD","LU1894683348.USD","BK4592","LU1894683264.USD","BK4533","SGXZ57979304.SGD","IE00B19Z3B42.SGD","BK4568","LU1023059063.AUD","LU0170899867.USD","PFE","SG9999001176.USD","LU0234572021.USD","SG9999002224.SGD","LU0321505868.SGD","BK4581","SG9999011175.SGD"],"gpt_icon":1},{"id":"2528279874","title":"Novavax (NasdaqGS:NVAX) Study Shows Reduced Symptoms With New COVID-19 Vaccine Formula","url":"https://stock-news.laohu8.com/highlight/detail?id=2528279874","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528279874?lang=en_us&edition=fundamental","pubTime":"2025-04-17 01:47","pubTimestamp":1744825666,"startTime":"0","endTime":"0","summary":"Novavax recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine, Adjuvanted, compared to Pfizer-BioNTech's offering. Despite this positive development, the company's stock performance last week was largely flat, rising 1%, amid broader market fluctuations driven by U.S. restrictions on chip exports to China. The Dow Jones, S&P 500, and Nasdaq all experienced notable declines, with technology stocks leading the downturn. In this context, the encouraging vaccine news from Novavax likely provided a stabilizing influence against broader market trends.We've spotted 2 possible red flags for Novavax you should be aware of, and 1 of them is significant.NasdaqGS:NVAX Revenue & Expenses Breakdown as at Apr 2025. With regards to Novavax's recent achievements, the preliminary SHIELD-Utah study results could positively influence revenue and earnings forecasts due to increased consumer confi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novavax-nasdaqgs-nvax-study-shows-174746964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4547","BK4548","BK4588","BK4535","NVAX","BK4568","BK4551","BNTX","BK4139"],"gpt_icon":0},{"id":"2528221121","title":"BUZZ-Abbott on track for best day in 2 years after reaffirming forecast amid tariff risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2528221121","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528221121?lang=en_us&edition=fundamental","pubTime":"2025-04-17 00:21","pubTimestamp":1744820494,"startTime":"0","endTime":"0","summary":"BUZZ-Abbott on track for best day in 2 years after reaffirming forecast amid tariff risksUpdates** Shares of medical device maker Abbott ABT.N rise 5.4% to $133.05** ABT is the top performer on the S&P 500 .SPX index on Wednesday. ** Stock has its best day since April 2023, if gains hold. ** ABT, in a conference call, says it doesn't expect any tariff impact in Q2** Impact of tariffs is projected to be a few hundred million dollars in 2025 - company ** ABT reaffirms its annual profit per share forecast of between $5.05 and $5.25, but beats Q1 earnings estimate** Company says two new manufacturing and R&D investments in Illinois and Texas, totaling $500 million, are projected to go live by the end of 2025** Up to last close, stock up 11.6% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL4N3QU18F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1691799644.USD","BK4533","LU2089984988.USD","BK4592","BK4581","LU1057294990.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2237957811.SGD","IE0009355771.USD","SG9999004303.SGD","IE00B2B36J28.USD","LU0234572021.USD","LU1061106388.HKD","SG9999002232.USD","BK4568","LU1914381329.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2133065610.SGD","IE00BJJMRZ35.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","LU1721429741.USD","LU0868494617.USD","LU1721429402.USD","SG9999002224.SGD","BK4588","BK4566","BK4082","BK4504","LU0170899867.USD","LU0266013472.USD","LU0122379950.USD","SGXZ23171101.USD","ABT","IE0002141913.USD","LU2237957902.USD","BK4585","LU1989763690.USD","LU1989763427.SGD"],"gpt_icon":0},{"id":"2528322647","title":"Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®","url":"https://stock-news.laohu8.com/highlight/detail?id=2528322647","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528322647?lang=en_us&edition=fundamental","pubTime":"2025-04-16 23:45","pubTimestamp":1744818300,"startTime":"0","endTime":"0","summary":"Saint-Herblain , April 16, 2025 – Valneva SE , a specialty vaccine company, today announced its presence at the forthcoming 25th World Vaccine Congress, which will take place from April 21-24, 2025 at the Walter E. convention center in Washington, D.C. Under the leadership of the Companys Chief Executive Officer, Thomas Lingelbach, a team of Valnevas senior managers will participate in multiple events, including an important presentation on the Companys vaccine IXCHIQ, the world’s first licensed chikungunya vaccine.The Company will have a display in the exhibit area of the congress at booth #424.In the evening of April 22, Valneva will attend the Vaccine Industry Excellence Awards ceremony, where it is a finalist for the Best Biotech Award and Best Prophylactic Vaccine Award for VLA15, the most advanced Lyme disease vaccine candidate worldwide, currently in Phase 3, partnered with Pfizer.About IXCHIQ IXCHIQ is the world’s first licensed chikungunya vaccine available to address this sig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-participate-multiple-events-25th-154500336.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0306806265.USD","LU1023059063.AUD","LU0985481810.HKD","LU0289739699.SGD","LU1883839398.USD","SG9999003800.SGD","LU1057294990.SGD","BK4533","IE00BBT3K403.USD","IE00B19Z3581.USD","SG9999002232.USD","LU0122379950.USD","BK4581","BK4599","BK4568","SG9999002224.SGD","LU0456855351.SGD","VALN","LU0225771236.USD","LU0058720904.USD","LU0170899867.USD","IE00BLSP4452.SGD","SG9999001176.SGD","BK4550","BK4139","BK4534","LU0321505439.SGD","LU0234572021.USD","LU0306807586.USD","SG9999013999.USD","LU1066053197.SGD","LU0868494617.USD","BK4007","LU1066051498.USD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","LU1894683264.USD","BK4588","LU0321505868.SGD","IE0002270589.USD","LU1894683348.USD","SG9999011175.SGD","INRLF","BK4592","IE000M9KFDE8.USD","SGXZ57979304.SGD","SG9999001176.USD","BK4585","LU0225284248.USD"],"gpt_icon":1},{"id":"2527225367","title":"Is Johnson & Johnson (JNJ) the Best Dividend Monarch to Invest in Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527225367","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527225367?lang=en_us&edition=fundamental","pubTime":"2025-04-16 23:19","pubTimestamp":1744816759,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where Johnson & Johnson  stands against other best dividend monarchs.Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware of a lesser-known group called Dividend Monarchs. While they fall under the broader category of dividend growth stocks, they carry a distinct title. The Dividend Monarchs Index highlights US companies that have managed to raise their dividends consistently for at least 50 consecutive years. These firms have weathered decades of market ups and downs, showcasing both resilience and steady performance in terms of dividend growth and stock returns. As an evolution of the well-known S&P Dividend Aristocrats Index Series, the S&P Dividend Monarchs Index sets an even higher standard, recognizing a more exclusive tier of long-term dividend payers.Although the Div","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-jnj-best-dividend-151919763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1674673691.USD","LU2592432038.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","LU0882574055.USD","BK4592","IE000M9KFDE8.USD","IE00B42XCP33.USD","BK4568","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","LU0122379950.USD","LU0912757837.SGD","BK4550","BK4534","ROE","IE0034235303.USD","LU1066051498.USD","IE00BSNM7G36.USD","JNJ","LU1032466523.USD","LU0234570918.USD","LU1196500208.SGD","IE00BBT3K403.USD","IE00B3T34201.USD","LU1261432733.SGD","IE00B1BXHZ80.USD","LU1066051225.USD","SG9999002232.USD","LU2602419157.SGD","LU0345770993.USD","LU1894683264.USD","LU0203347892.USD","IE00BVYPNW00.USD","IE00BVYPNV92.GBP","IE00BGHQF631.EUR","LU0795875086.SGD","LU1023059063.AUD","LU1244550221.USD","LU1162221912.USD","LU1732800096.USD","LU2089984988.USD","IE00BJT1NW94.SGD","BK4533","IE00B7SZLL34.SGD","LU0795875169.SGD","BK4588","LU0466842654.USD","LU0889566641.SGD","LU0203345920.USD"],"gpt_icon":0},{"id":"2527822831","title":"Abbott Labs Forecasts Tariff Impact of a 'Few Hundred Million Dollars' -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2527822831","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527822831?lang=en_us&edition=fundamental","pubTime":"2025-04-16 23:19","pubTimestamp":1744816740,"startTime":"0","endTime":"0","summary":"Abbott Laboratories forecasts an impact of \"a few hundred million dollars\" this year from Trump administration tariffs, Chief Executive Robert Ford told analysts Wednesday.The healthcare company sees the costs starting in the third quarter. Ford told analysts it is too early to simply double the 2025 estimate for how tariffs might affect Abbott in future years, but the company can cover them in the near term.Illinois-based Abbott's products include baby formula and medical devices, with some devices imported from overseas. The company is studying how to mitigate tariffs long term, and expects its global manufacturing network to help with those efforts, Ford said.\"One thing we have learned from tariffs is they don't go away, so whatever comes it stays, and it stays for a while,\" he said. \"Look at the tariffs that went in place in 2017. They're still there.\". This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL .","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2237957902.USD","LU2089984988.USD","BK4581","LU0234572021.USD","LU2133065610.SGD","BK4592","LU0266013472.USD","SGXZ23171101.USD","BK4082","IE00B2B36J28.USD","LU0170899867.USD","LU1691799644.USD","BK4504","BK4566","SG9999004303.SGD","SG9999002224.SGD","IE0002141913.USD","LU1023059063.AUD","LU1721429741.USD","BK4533","LU1914381329.SGD","LU1061106388.HKD","LU2112291526.USD","LU0868494617.USD","LU1721429402.USD","LU1989763427.SGD","BK4588","LU2237957811.SGD","IE00B4R5TH58.HKD","LU2468319806.SGD","ABT","BK4568","LU1989763690.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","SG9999002232.USD","LU0122379950.USD","IE0009355771.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2527900842","title":"Abbott Maintains Profit Forecast, Invests $500 Million in US Amid Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527900842","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527900842?lang=en_us&edition=fundamental","pubTime":"2025-04-16 22:12","pubTimestamp":1744812764,"startTime":"0","endTime":"0","summary":"Abbott invests $500 million in US amid tariff uncertaintyProjects in Illinois and Texas to start by year-endAbbott's Q1 profit beats estimates, glucose monitor sales rise(Reuters) - Abbott Laboratorie","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL4N3QU0UW:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Abbott Maintains Profit Forecast, Invests $500 Million in US Amid Tariffs","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2237957902.USD","BK4566","LU1023059063.AUD","LU1057294990.SGD","BK4533","LU1061106388.HKD","LU1989763690.USD","IE0002141913.USD","SG9999002232.USD","IE00B2B36J28.USD","LU0122379950.USD","BK4581","BK4568","LU2089984988.USD","SG9999002224.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0170899867.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU1691799644.USD","LU0234572021.USD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4504","SG9999004303.SGD","BK4588","LU1914381329.SGD","LU1721429741.USD","IE00BJJMRZ35.SGD","LU2237957811.SGD","LU2133065610.SGD","BK4592","SGXZ23171101.USD","LU1721429402.USD","LU1989763427.SGD","BK4585","LU0266013472.USD","ABT"],"gpt_icon":1},{"id":"2527246760","title":"Abbott Labs sees demand for diabetes products jump, and the stock surges","url":"https://stock-news.laohu8.com/highlight/detail?id=2527246760","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527246760?lang=en_us&edition=fundamental","pubTime":"2025-04-16 22:01","pubTimestamp":1744812060,"startTime":"0","endTime":"0","summary":"Abbott extends its long streak of earnings beats, and the stock surges to lead the S&P 500 index's gainers. Abbott Laboratories saw a big jump in demand for its diabetes products in the first quarter, which helped the medical-device company extend its long streak of earnings beats and propelled its stock to a healthy gain Wednesday.Sales of diabetes-care products for the quarter to March 31 surged 16.5% from a year ago to $1.83 billion, boosted by an 18.3% jump in sales of continuous glucose monitors. That was part of the 9.9% growth in sales of medical devices to $4.9 billion, which topped the average analyst estimate compiled by FactSet of $4.86 billion.The company also reaffirmed its previously provided full-year financial guidance. Abbott Labs expects full-year 2025 organic sales growth in the range of 7.5% to 8.5% and full-year adjusted earnings of $5.05 to $5.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","OEX","LU2237957902.USD",".SPX","LU1023059063.AUD","BK4533","LU1061106388.HKD","LU1989763690.USD","ESmain","IE0002141913.USD","SG9999002232.USD","IE00B2B36J28.USD","LU0122379950.USD","BK4568","VOO","LU2089984988.USD","SG9999002224.SGD","IE00BFTCPJ56.SGD","SDS","LU0170899867.USD","LU2112291526.USD","SH","BK4550","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4534","LU1691799644.USD","SSO","IE00B4R5TH58.HKD","IVV","LU0868494617.USD","SPY","BK4504","BK4559","SG9999004303.SGD","BK4588","LU1914381329.SGD","LU1721429741.USD","IE00BJJMRZ35.SGD","LU2237957811.SGD","LU2133065610.SGD","BK4592","SGXZ23171101.USD","LU1721429402.USD","OEF","BK4585","LU0266013472.USD","ABT"],"gpt_icon":1},{"id":"2527324143","title":"Is Gilead Sciences Inc. (NASDAQ:GILD) the Most Undervalued Quality Stock to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527324143","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527324143?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:54","pubTimestamp":1744811662,"startTime":"0","endTime":"0","summary":"We recently published a list of the 11 Most Undervalued Quality Stocks to Buy Now. In this article, we are going to take a look at where Gilead Sciences Inc.  stands against other undervalued quality stocks to buy now.On February 24, Kayne Anderson Rudnick chief market strategist Julie Biel joined ‘The Exchange’ on CNBC to discuss her thoughts on how good quality companies can ride out turbulence in the market. Just like Warren Buffett and Charlie Munger, Biel also suggests inaction as an investment principle and believes that holding high-quality companies can help investors deal with market volatility. She emphasized conviction in investing instead of impulsive decision-making. Biel also noted the general resilience of the US economy, which mainly comes from a robust jobs market as it fuels the consumer-driven economy. She also expressed unease over the limited tools available to address a potential recession that could come from high levels of deficit spending. She thinks inefficien","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-inc-nasdaq-gild-135422051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","IE0002270589.USD","QID","LU0320765992.SGD","LU1571399168.USD","LU1066051498.USD","LU2468319806.SGD","BK4566","IE00B64PRP62.GBP","QLD","NQmain","BK4532","GILD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4550","MNQmain","SQQQ","IE00B19Z3581.USD","PSQ","BK4585",".IXIC","BK4139","BK4583","BK4588","IE00BKPKM429.USD","LU2210150020.SGD","TQQQ","BK4112","IE00BKVL7J92.USD","BK4578","LU0234570918.USD","USAW.SI","USJW.SI","IE00B3QW5Z07.USD","BK4568","LU2095319765.USD","LU0109394709.USD","IE00B3T34201.USD","LU0058720904.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","LU1839511570.USD","LU2210149790.SGD","NVIW.SI","TSYW.SI","NDAQ","LU1430594728.SGD","IE00BSNM7G36.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":14,"pageCount":6,"totalSize":265,"code":"91000000","status":"200"}]}}